Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Effect of Spironolactone on Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: Post-Hoc Analysis of the Randomized, Placebo-Controlled TOPCAT Trial.

Neefs J, van den Berg NWE, Krul SPJ, Boekholdt SM, de Groot JR.

Am J Cardiovasc Drugs. 2019 Jun 19. doi: 10.1007/s40256-019-00353-5. [Epub ahead of print]

PMID:
31214914
2.

Body mass index and body fat distribution and new-onset atrial fibrillation: Substudy of the European Prospective Investigation into Cancer and Nutrition in Norfolk (EPIC-Norfolk) study.

Neefs J, Boekholdt SM, Khaw KT, Luben R, Pfister R, Wareham NJ, Meulendijks ER, Sanders P, de Groot JR.

Nutr Metab Cardiovasc Dis. 2019 Jul;29(7):692-700. doi: 10.1016/j.numecd.2019.03.005. Epub 2019 Mar 15.

PMID:
31079869
3.

Additional Ganglion Plexus Ablation During Thoracoscopic Surgical Ablation of Advanced Atrial Fibrillation: Intermediate Follow-Up of the AFACT Study.

Berger WR, Neefs J, van den Berg NWE, Krul SPJ, van Praag EM, Piersma FR, de Jong JSSG, van Boven WP, Driessen AHG, de Groot JR.

JACC Clin Electrophysiol. 2019 Mar;5(3):343-353. doi: 10.1016/j.jacep.2018.10.008. Epub 2018 Nov 28.

4.

Persistent atrial fibrillation: A systematic review and meta-analysis of invasive strategies.

Berger WR, Meulendijks ER, Limpens J, van den Berg NWE, Neefs J, Driessen AHG, Krul SPJ, van Boven WJP, de Groot JR.

Int J Cardiol. 2019 Mar 1;278:137-143. doi: 10.1016/j.ijcard.2018.11.127. Epub 2018 Nov 29.

5.

Comparison of non-triggered magnetic resonance imaging and echocardiography for the assessment of left atrial volume and morphology.

van den Berg NWE, Chan Pin Yin DRPP, Berger WR, Neefs J, De Bruin-Bon RHACM, Marquering HA, Slaar A, Planken RN, de Groot JR.

Cardiovasc Ultrasound. 2018 Sep 18;16(1):17. doi: 10.1186/s12947-018-0134-y.

6.

Can we spice up our Christmas dinner? : Busting the myth of the 'Chinese restaurant syndrome'.

van den Berg NWE, Neefs J, Berger WR, Baalman SWE, Meulendijks E, Kawasaki M, Kemper EM, Piersma FR, Veldkamp MW, Wesselink R, Krul SPJ, de Groot JR.

Neth Heart J. 2017 Dec;25(12):664-668. doi: 10.1007/s12471-017-1053-5.

7.

Protocols for the Design of Kinase-focused Compound Libraries.

Jacoby E, Wroblowski B, Buyck C, Neefs JM, Meyer C, Cummings MD, van Vlijmen H.

Mol Inform. 2018 May;37(5):e1700119. doi: 10.1002/minf.201700119. Epub 2017 Nov 8.

PMID:
29116686
8.

Quality of life improves after thoracoscopic surgical ablation of advanced atrial fibrillation: Results of the Atrial Fibrillation Ablation and Autonomic Modulation via Thoracoscopic Surgery (AFACT) study.

Driessen AHG, Berger WR, Bierhuizen MFA, Piersma FR, van den Berg NWE, Neefs J, Krul SPJ, van Boven WP, de Groot JR.

J Thorac Cardiovasc Surg. 2018 Mar;155(3):972-980. doi: 10.1016/j.jtcvs.2017.09.093. Epub 2017 Sep 27.

PMID:
29089093
9.

MicroRNAs in Atrial Fibrillation: from Expression Signatures to Functional Implications.

van den Berg NWE, Kawasaki M, Berger WR, Neefs J, Meulendijks E, Tijsen AJ, de Groot JR.

Cardiovasc Drugs Ther. 2017 Jun;31(3):345-365. doi: 10.1007/s10557-017-6736-z. Review.

10.

Response to "comment on "aldosterone pathway blockade to prevent atrial fibrillation: A systematic review and meta-analysis" by Neefs et al."

Neefs J, van den Berg NWE, Limpens J, Berger WR, Boekholdt SM, Sanders P, de Groot JR.

Int J Cardiol. 2017 Sep 1;242:23. doi: 10.1016/j.ijcard.2017.03.007. No abstract available.

11.

The change in circulating galectin-3 predicts absence of atrial fibrillation after thoracoscopic surgical ablation.

Berger WR, Jagu B, van den Berg NWE, Chan Pin Yin DRPP, van Straalen JP, de Boer OJ, Driessen AHG, Neefs J, Krul SPJ, van Boven WP, van der Wal AC, de Groot JR.

Europace. 2018 May 1;20(5):764-771. doi: 10.1093/europace/eux090.

PMID:
28525549
12.

Electrophysiologically Guided Thoracoscopic Surgery for Advanced Atrial Fibrillation: 5-Year Follow-up.

Driessen AH, Berger WR, Chan Pin Yin DR, Piersma FR, Neefs J, van den Berg NW, Krul SP, van Boven WP, de Groot JR.

J Am Coll Cardiol. 2017 Apr 4;69(13):1753-1754. doi: 10.1016/j.jacc.2017.01.035. No abstract available.

13.

Aldosterone Pathway Blockade to Prevent Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Neefs J, van den Berg NW, Limpens J, Berger WR, Boekholdt SM, Sanders P, de Groot JR.

Int J Cardiol. 2017 Mar 15;231:155-161. doi: 10.1016/j.ijcard.2016.12.029. Epub 2016 Dec 23. Review.

14.

Open PHACTS computational protocols for in silico target validation of cellular phenotypic screens: knowing the knowns.

Digles D, Zdrazil B, Neefs JM, Van Vlijmen H, Herhaus C, Caracoti A, Brea J, Roibás B, Loza MI, Queralt-Rosinach N, Furlong LI, Gaulton A, Bartek L, Senger S, Chichester C, Engkvist O, Evelo CT, Franklin NI, Marren D, Ecker GF, Jacoby E.

Medchemcomm. 2016 Jun 1;7(6):1237-1244. Epub 2016 May 11.

15.

Ganglion Plexus Ablation in Advanced Atrial Fibrillation: The AFACT Study.

Driessen AHG, Berger WR, Krul SPJ, van den Berg NWE, Neefs J, Piersma FR, Chan Pin Yin DRPP, de Jong JSSG, van Boven WP, de Groot JR.

J Am Coll Cardiol. 2016 Sep 13;68(11):1155-1165. doi: 10.1016/j.jacc.2016.06.036.

16.

Extending kinome coverage by analysis of kinase inhibitor broad profiling data.

Jacoby E, Tresadern G, Bembenek S, Wroblowski B, Buyck C, Neefs JM, Rassokhin D, Poncelet A, Hunt J, van Vlijmen H.

Drug Discov Today. 2015 Jun;20(6):652-8. doi: 10.1016/j.drudis.2015.01.002. Epub 2015 Jan 14. Review.

PMID:
25596550
17.

The application of the open pharmacological concepts triple store (open PHACTS) to support drug discovery research.

Ratnam J, Zdrazil B, Digles D, Cuadrado-Rodriguez E, Neefs JM, Tipney H, Siebes R, Waagmeester A, Bradley G, Chau CH, Richter L, Brea J, Evelo CT, Jacoby E, Senger S, Loza MI, Ecker GF, Chichester C.

PLoS One. 2014 Dec 18;9(12):e115460. doi: 10.1371/journal.pone.0115460. eCollection 2014.

18.

Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism.

Koul A, Vranckx L, Dhar N, Göhlmann HW, Özdemir E, Neefs JM, Schulz M, Lu P, Mørtz E, McKinney JD, Andries K, Bald D.

Nat Commun. 2014 Feb 26;5:3369. doi: 10.1038/ncomms4369.

19.

Nociceptive and behavioural sensitisation by protein kinase Cepsilon signalling in the CNS.

Van Kolen K, Pullan S, Neefs JM, Dautzenberg FM.

J Neurochem. 2008 Jan;104(1):1-13. Epub 2007 Oct 30. Review.

20.

Downregulation of two novel genes in Sl/Sld and W(LacZ)/Wv mouse jejunum.

Wouters MM, Neefs JM, Kerchove d'Exaerde Ad, Vanderwinden JM, Smans KA.

Biochem Biophys Res Commun. 2006 Jul 28;346(2):491-500. Epub 2006 Jun 2.

PMID:
16765319
21.

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.

Andries K, Verhasselt P, Guillemont J, Göhlmann HW, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, Williams P, de Chaffoy D, Huitric E, Hoffner S, Cambau E, Truffot-Pernot C, Lounis N, Jarlier V.

Science. 2005 Jan 14;307(5707):223-7. Epub 2004 Dec 9.

22.

A putative white adipose tissue specific nuclear orphan receptor that interacts with the cAMP-response element of the human beta3-adrenergic receptor gene.

Kutoh E, Ongenae N, Claeskens A, Verheyen W, Cheyns P, Neefs J, Kaijen P.

Mol Cell Endocrinol. 2000 Jul 25;165(1-2):85-95.

PMID:
10940487
23.

Cloning and characterization of human histone deacetylase 8.

Van den Wyngaert I, de Vries W, Kremer A, Neefs J, Verhasselt P, Luyten WH, Kass SU.

FEBS Lett. 2000 Jul 28;478(1-2):77-83.

24.

Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation.

Claeskens A, Ongenae N, Neefs JM, Cheyns P, Kaijen P, Cools M, Kutoh E.

Br J Cancer. 2000 Mar;82(6):1123-30.

25.

Isolation and expression of novel human glutamate carboxypeptidases with N-acetylated alpha-linked acidic dipeptidase and dipeptidyl peptidase IV activity.

Pangalos MN, Neefs JM, Somers M, Verhasselt P, Bekkers M, van der Helm L, Fraiponts E, Ashton D, Gordon RD.

J Biol Chem. 1999 Mar 26;274(13):8470-83.

26.

Structure of the human histamine H1 receptor gene.

De Backer MD, Loonen I, Verhasselt P, Neefs JM, Luyten WH.

Biochem J. 1998 Nov 1;335 ( Pt 3):663-70.

27.
28.

Reconstructing evolution from eukaryotic small-ribosomal-subunit RNA sequences: calibration of the molecular clock.

Van de Peer Y, Neefs JM, De Rijk P, De Wachter R.

J Mol Evol. 1993 Aug;37(2):221-32.

PMID:
8411212
29.

Compilation of small ribosomal subunit RNA structures.

Neefs JM, Van de Peer Y, De Rijk P, Chapelle S, De Wachter R.

Nucleic Acids Res. 1993 Jul 1;21(13):3025-49.

30.

Compilation of small ribosomal subunit RNA sequences.

De Rijk P, Neefs JM, Van de Peer Y, De Wachter R.

Nucleic Acids Res. 1992 May 11;20 Suppl:2075-89. No abstract available.

31.

The gene coding for small ribosomal subunit RNA in the basidiomycete Ustilago maydis contains a group I intron.

De Wachter R, Neefs JM, Goris A, Van de Peer Y.

Nucleic Acids Res. 1992 Mar 25;20(6):1251-7.

32.

Phylogenetic analysis of five medically important Candida species as deduced on the basis of small ribosomal subunit RNA sequences.

Hendriks L, Goris A, Van de Peer Y, Neefs JM, Vancanneyt M, Kersters K, Hennebert GL, De Wachter R.

J Gen Microbiol. 1991 May;137(5):1223-30.

PMID:
1865186
33.

Compilation of small ribosomal subunit RNA sequences.

Neefs JM, Van de Peer Y, De Rijk P, Goris A, De Wachter R.

Nucleic Acids Res. 1991 Apr 25;19 Suppl:1987-2015. Review. No abstract available.

36.

The 18S ribosomal RNA sequence of the sea anemone Anemonia sulcata and its evolutionary position among other eukaryotes.

Hendriks L, Van de Peer Y, Van Herck M, Neefs JM, De Wachter R.

FEBS Lett. 1990 Sep 3;269(2):445-9.

37.
38.

Compilation of small ribosomal subunit RNA sequences.

Neefs JM, Van de Peer Y, Hendriks L, De Wachter R.

Nucleic Acids Res. 1990 Apr 25;18 Suppl:2237-317. No abstract available.

39.

Compilation of small ribosomal subunit RNA sequences.

Dams E, Hendriks L, Van de Peer Y, Neefs JM, Smits G, Vandenbempt I, De Wachter R.

Nucleic Acids Res. 1988;16 Suppl:r87-173. No abstract available.

40.

A quantitative measurement of sweat production after local injection of adrenalin.

Warndorff JA, Neefs J.

J Invest Dermatol. 1971 May;56(5):384-6. No abstract available.

Supplemental Content

Support Center